We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMIRSH TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing (Note 1) Millennium International Management LP Company dealt in Allergan plc Class of relevant security to which IE00BY9D5467 the dealings being disclosed relate (Note 2) Date of dealing 11(th) May 2020
2. INTERESTS AND SHORT POSITIONS
1. Interests and short positions (following dealing) in the class ofrelevant security dealt in(Note 3) Long Short Number (%) Number (%) (1) Relevant securities 0 0 (0.000%) (0.000%) (2) Derivatives (other than options) - - (3) Options and agreements to purchase/sell - - Total 0 0 (0.000%) (0.000%)
b. Interests and short positionsin relevant securitiesof the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total
Ap20
3. DEALINGS (Note 4)
1. Purchases and sales Price per unit (Note 5) Purchase/sale Number of relevant securities (USD) Sale 130,165 193.01 Sale 965,039 193.01 Sale 415,101 193.01 Sale 276,702 193.01 Sale 645,796 193.01 Sale 5,979 193.01 Purchase 133 193.01 Purchase 14,619 193.01 Sale 1,688,153 193.01 Purchase 2,580 193.01 Sale 8 193.01 Purchase 3,721,191 193.01 Sale 3,826,467 193.01 Sale 1,270,619 193.01 1. Exercising Product name, Number of securities Exercise price per unit (Note 5) e.g. call option
b. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None.
Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 12(th) May 2020 Contact name Milos Naumovic Telephone number +44 203 650 8203 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10)
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005523/en/
CONTACT:
Millennium Partners, L.P.
SOURCE: Millennium Partners, L.P. Copyright Business Wire 2020
(END) Dow Jones Newswires
May 12, 2020 10:15 ET (14:15 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions